AJR ARRS Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JOHNSON, H. F.
Right arrow Articles by PERRY, R. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by JOHNSON, H. F.
Right arrow Articles by PERRY, R. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
American Journal of Roentgenology, Vol 102, 608-612, Copyright © 1968 by American Roentgen Ray Society


TREATMENT OF LYMPHOMAS WITH MEDIUM KILOVOLTAGE EQUIPMENT AND INCIDENCE OF RECURRENCES

HERBERT F. JOHNSON M.D.1 and RONALD H. PERRY 2

1 Radiology Service, Tampa General Hospital, Tampa, Florida
2 Radiation Therapy Section, Radiology Service, Walter Reed General Hospital, Walter Reed Army Medical Center, Washington, D. C.

1. In spite of the variable dose initially used in the treatment of Hodgkin's disease, the long term survival is in the general range as compared to institutions where the initial tumor dose is above 2,500 r; however, the problem of local recurrences and subsequent retreatment to local sites remains a problem in cases where the initial tumor dose is below 3,000 r.

2. The response of lymphosarcoma, reticulum cell sarcoma and giant follicular lymphoma, as treated at this institution, does not indicate a homogeneous group as reported from other institutions. Only the giant follicular lymphoma appears to hold a satisfactory survival rate when treated by means of medium voltage therapy.

3. On the basis of our material, it would appear that an effort should be made to have patients with lymphosarcoma and reticulum cell sarcoma treated at institutions where supervoltage or cobalt 6o therapy is available.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1968 by the American Roentgen Ray Society.